Orient EuroPharma Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	1,950	1,435	1,736	1,801	1,959
Short-Term Investments	172.71	174.26	159.52	70.8	80.8
Cash & Short-Term Investments	2,122	1,609	1,896	1,872	2,040
Cash Growth	31.88%	-15.10%	1.27%	-8.25%	-12.19%
Accounts Receivable	817.68	847.2	783.01	730.48	580.03
Other Receivables	26.72	21.44	26.94	27.66	33.53
Receivables	844.41	868.64	809.94	758.15	613.55
Inventory	1,086	1,065	1,147	1,304	1,082
Prepaid Expenses	184	137.26	118.23	162.21	136.07
Other Current Assets	60.82	295.84	257.28	88.62	53.63
Total Current Assets	4,298	3,976	4,228	4,185	3,925
Property, Plant & Equipment	3,857	3,851	3,986	4,019	4,181
Long-Term Investments	2,607	2,296	1,064	533.57	416.83
Other Intangible Assets	51.45	43.76	42.69	43.01	78.16
Long-Term Deferred Tax Assets	605.58	623.1	677.16	588.05	631.87
Other Long-Term Assets	788.45	780.13	814.28	1,062	170.82
Total Assets	12,208	11,570	10,812	10,430	9,403
Accounts Payable	155.64	176.13	348.07	552.2	159.81
Accrued Expenses	-	296.94	274.85	353.04	390.66
Short-Term Debt	1,718	2,112	2,324	2,191	2,050
Current Portion of Long-Term Debt	349.91	379.89	272.31	350.18	246.82
Current Portion of Leases	26.09	38.79	41.95	44.06	25.78
Current Income Taxes Payable	129.2	20.21	138.39	16.02	55.52
Other Current Liabilities	535.46	283.6	312.65	286.42	303.12
Total Current Liabilities	2,915	3,308	3,712	3,793	3,232
Long-Term Debt	924.97	1,343	1,790	1,991	1,680
Long-Term Leases	307.64	354.37	412.89	447.92	218.46
Pension & Post-Retirement Benefits	-	47	58.69	59.82	66.99
Long-Term Deferred Tax Liabilities	640.39	670.13	651.99	671.26	728.29
Other Long-Term Liabilities	66.72	22.9	23.44	23.3	24.65
Total Liabilities	4,854	5,746	6,649	6,987	5,950
Common Stock	867.47	867.47	867.47	867.47	867.47
Additional Paid-In Capital	518.46	271.26	271.26	271.26	263.44
Retained Earnings	3,666	2,046	1,752	1,738	2,118
Comprehensive Income & Other	1,236	1,979	624.12	51.9	-307.04
Total Common Equity	6,287	5,164	3,514	2,929	2,942
Minority Interest	1,066	660.39	648	514.77	511.39
Shareholders' Equity	7,354	5,824	4,162	3,444	3,453
Total Liabilities & Equity	12,208	11,570	10,812	10,430	9,403
Total Debt	3,327	4,229	4,841	5,024	4,221
Net Cash (Debt)	-1,204	-2,620	-2,946	-3,153	-2,181
Net Cash Per Share	-13.88	-30.20	-33.88	-36.34	-25.08
Filing Date Shares Outstanding	86.79	86.75	86.75	86.75	86.75
Total Common Shares Outstanding	86.79	86.75	86.75	86.75	86.75
Working Capital	1,383	667.71	515.42	391.79	693.29
Book Value Per Share	72.45	59.53	40.51	33.76	33.91
Tangible Book Value	6,236	5,120	3,472	2,886	2,864
Tangible Book Value Per Share	71.85	59.03	40.02	33.27	33.01
Land	-	1,157	1,169	1,169	1,462
Buildings	-	2,300	2,347	2,243	2,190
Machinery	-	1,083	1,069	992.9	965.5
Construction In Progress	-	27.78	3.55	36.12	48.41

Source: S&P Global Market Intelligence. Standard template. Financial Sources.